Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1400 of 1467 entries
View as:

Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00564187 Org: User:
Start: 02/28/03 End: 12/31/04 Due: 12/31/05

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1

Phase: N/A Priority: Normal
NCT ID: NCT06844214 Org: User:
Start: 04/29/25 End: 02/28/30 Due: 02/28/31

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00331838 Org: User:
Start: 05/31/06 End: 06/30/07 Due: 06/30/08

Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02404558 Org: User:
Start: 05/31/15 End: 03/31/16 Due: 03/31/17

A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06192563 Org: User:
Start: 11/30/23 End: 01/31/26 Due: 01/31/27

LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00349986 Org: User:
Start: 09/30/06 End: - Due: -

Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01129063 Org: User:
Start: 03/31/09 End: 05/31/09 Due: 05/31/10

A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06073093 Org: User:
Start: 11/07/23 End: 07/02/25 Due: 07/02/26

Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)

Phase: N/A Priority: Normal
NCT ID: NCT01047566 Org: User:
Start: 04/30/10 End: 09/30/11 Due: 09/30/12

A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06630806 Org: User:
Start: 10/30/24 End: 05/14/29 Due: 05/14/30

A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05858788 Org: User:
Start: 05/15/23 End: 07/17/23 Due: 07/17/24

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Phase: N/A Priority: Normal
NCT ID: NCT00290953 Org: User:
Start: 10/31/02 End: 03/31/06 Due: 03/31/07

Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT00443287 Org: User:
Start: 02/28/07 End: 10/31/08 Due: 10/31/09

Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01129427 Org: User:
Start: 08/31/09 End: 11/30/09 Due: 11/30/10

Long-Term Safety Performance of Fexofenadine in Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00045955 Org: User:
Start: 02/28/02 End: 11/30/03 Due: 11/30/04

Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04171310 Org: User:
Start: 11/13/19 End: 12/30/19 Due: 12/30/20

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart

Phase: N/A Priority: Normal
NCT ID: NCT01159353 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09

A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00981175 Org: User:
Start: 04/30/03 End: 02/29/08 Due: 02/28/09

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05097287 Org: User:
Start: 12/16/21 End: 01/22/30 Due: 01/22/31

Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00317395 Org: User:
Start: 06/30/06 End: 03/31/09 Due: 03/31/10

Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media

Phase: N/A Priority: Normal
NCT ID: NCT00638534 Org: User:
Start: 02/29/04 End: 10/31/04 Due: 10/31/05

A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00532155 Org: User:
Start: 09/30/07 End: 10/31/11 Due: 10/31/12

Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)

Phase: N/A Priority: Normal
NCT ID: NCT00070655 Org: User:
Start: 09/30/03 End: 03/31/06 Due: 03/31/07

Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00174863 Org: User:
Start: 10/31/03 End: 08/31/06 Due: 08/31/07

Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)

Phase: N/A Priority: Normal
NCT ID: NCT03798054 Org: User:
Start: 02/15/19 End: 03/01/21 Due: 03/01/22